Notice2023-01330
Foreign-Trade Zone (FTZ) 30-Salt Lake City, Utah, Notification of Proposed Production Activity, Albion Laboratories, Inc. (Mineral Amino Acid Chelates), Ogden, Utah
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
January 24, 2023
Issuing agencies
Commerce DepartmentForeign-Trade Zones Board
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 15 (Tuesday, January 24, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 15 (Tuesday, January 24, 2023)]
[Notices]
[Page 4152]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-01330]
[[Page 4152]]
-----------------------------------------------------------------------
DEPARTMENT OF COMMERCE
Foreign-Trade Zones Board
[B-6-2023]
Foreign-Trade Zone (FTZ) 30--Salt Lake City, Utah, Notification
of Proposed Production Activity, Albion Laboratories, Inc. (Mineral
Amino Acid Chelates), Ogden, Utah
Albion Laboratories, Inc. (Albion) submitted a notification of
proposed production activity to the FTZ Board (the Board) for its
facilities in Ogden, Utah, within Subzone 30E. The notification
conforming to the requirements of the Board's regulations (15 CFR
400.22) was received on January 13, 2023.
Pursuant to 15 CFR 400.14(b), FTZ production activity would be
limited to the specific foreign-status materials/components and
specific finished products described in the submitted notification
(summarized below) and subsequently authorized by the Board. The
benefits that may stem from conducting production activity under FTZ
procedures are explained in the background section of the Board's
website--accessible via <a href="http://www.trade.gov/ftz">www.trade.gov/ftz</a>.
The proposed finished products include: calcium bisglycinate;
calcium citrate malate; calcium potassium phosphate citrate; chromium
nicotinate glycinate chelate; copper bisglycinate; dicalcium malate;
dimagnesium malate; ferric glycinate; ferrous bisglycinate; magnesium
creatine; magnesium bisglycinate; magnesium lysinate glycinate;
manganese bisglycinate; selenium glycinate; and, zinc bisglycinate
chelate (duty rate ranges from 3.7% to 6.5%).
The proposed foreign-status materials and components include
glycine (aminoacetic acid) and malic acid (duty rates are 4.2% and 4%,
respectively). The request indicates that glycine is subject to
antidumping/countervailing duty (AD/CVD) orders if imported from
certain countries. The Board's regulations (15 CFR 400.14(e)) require
that merchandise subject to AD/CVD orders, or items which would be
otherwise subject to suspension of liquidation under AD/CVD procedures
if they entered U.S. customs territory, be admitted to the zone in
privileged foreign (PF) status (19 CFR 146.41). The request also
indicates that both glycine and malic acid are subject to duties under
section 301 of the Trade Act of 1974 (section 301), depending on the
country of origin. The applicable Section 301 decisions require subject
merchandise to be admitted to FTZs in PF status. As requested, FTZ
authority would be subject to the following restrictions: that (1) all
finished products made with PF status glycine be exported, and (2) that
any approval for glycine be limited to five years.
Public comment is invited from interested parties. Submissions
shall be addressed to the Board's Executive Secretary and sent to:
<a href="/cdn-cgi/l/email-protection#2d4b59576d595f4c4948034a425b"><span class="__cf_email__" data-cfemail="036577794377716267662d646c75">[email protected]</span></a>. The closing period for their receipt is March 6, 2023.
A copy of the notification will be available for public inspection
in the ``Online FTZ Information System'' section of the Board's
website.
For further information, contact Diane Finver at
<a href="/cdn-cgi/l/email-protection#8acee3ebe4efa4cce3e4fceff8cafef8ebeeefa4ede5fc"><span class="__cf_email__" data-cfemail="96d2fff7f8f3b8d0fff8e0f3e4d6e2e4f7f2f3b8f1f9e0">[email protected]</span></a>.
Dated: January 19, 2023.
Elizabeth Whiteman,
Acting Executive Secretary.
[FR Doc. 2023-01330 Filed 1-23-23; 8:45 am]
BILLING CODE 3510-DS-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on January 24, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.